ARTICLE | Clinical News
PreGen-Plus regulatory update
January 23, 2006 8:00 AM UTC
EXAS disclosed that Laboratory Corp. of America Holdings (LH, Burlington, N.C.) received a letter from FDA stating that the PreGen-Plus colorectal cancer diagnostic test may require a PMA and be subje...